1.
Cell Metab
; 33(3): 473-478, 2021 03 02.
Article
in English
| MEDLINE | ID: covidwho-1074686
ABSTRACT
Chronic metabolic disorders such as diabetes and obesity are major public health issues in the United States. However, significant disparities in their prevalence and incidence place a greater burden on US racial and ethnic minority groups, contributing to worse COVID-19 outcomes in many. Improving treatment and prevention of diabetes and obesity is critical to the NIDDK. In this Perspective, we will review the burden of metabolic diseases in the United States, the observed disparities for metabolic diseases in relation to COVID-19, and research opportunities to address underlying causes of metabolic diseases, their associated health disparities, and COVID-19.
Subject(s)
COVID-19/epidemiology , Diabetes Mellitus/epidemiology , Healthcare Disparities/statistics & numerical data , Metabolic Diseases/epidemiology , Obesity/epidemiology , Ethnicity/statistics & numerical data , Humans , Minority Groups/statistics & numerical data , Research , SARS-CoV-2 , United States/epidemiology
2.
JAMA
; 324(12): 1163-1165, 2020 09 22.
Article
in English
| MEDLINE | ID: covidwho-885016
3.
JAMA
; 324(8): 735-736, 2020 Aug 25.
Article
in English
| MEDLINE | ID: covidwho-728030